Treatment of unipolar psychotic depression: The use of evidence in practice guidelines

Jaap Wijkstra*, Chris D. Schubart, Willem A. Nolen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)

Abstract

Introduction. In a recent meta-analysis we found no evidence that an antidepressant plus an antipsychotic is more effective than an antidepressant alone in unipolar psychotic depression. However, most current guidelines recommend the combination over an antidepressant alone. Method. We assessed available guidelines by the AGREE instrument and discuss their recommendations in relation to the evidence as referred to in the guidelines. Results. The UK-NICE guideline had the highest AGREE quality score, followed by the Dutch, Australian, and US-APA guidelines. Guidelines are not always consistent with at date of publication available evidence and (with exception of the UK-NICE and Dutch guidelines) also not with the in that guideline referred evidence. Conclusion. Physicians (and patients) should be aware that in guidelines treatment recommendations may be less evidence-based than asserted, even when treatment recommendations are stated as being based on the highest level of evidence.

Original languageEnglish
Pages (from-to)409-415
Number of pages7
JournalWorld journal of biological psychiatry
Volume10
Issue number4
DOIs
Publication statusPublished - 2009

Keywords

  • Affective disorders
  • psychotic
  • practice guidelines
  • DELUSIONAL DEPRESSION
  • DOUBLE-BLIND
  • PHARMACOLOGICAL-TREATMENT
  • PERPHENAZINE
  • METAANALYSIS
  • COMBINATION
  • FLUVOXAMINE
  • IMIPRAMINE

Fingerprint

Dive into the research topics of 'Treatment of unipolar psychotic depression: The use of evidence in practice guidelines'. Together they form a unique fingerprint.

Cite this